The National Science Foundation has awarded a $250,000 grant to BioAesthetics Corp. to develop a new advanced wound-care product for treating bed sores or pressure ulcers. The product will be tested at Tulane University.
The Small Business Technology Transfer (STTR) Phase I award will fund initial testing and development of a skin graft that combines the company’s tissue regeneration technology with infection-fighting drugs to better promote healing.
BioAesthetics’ founder and CEO Nick Pashos, PhD, and COO Billy Heim, are both Tulane alumni. BioAesthetics was spawned at Tulane in 2015 to commercialize a pioneering tissue graft Pashos, a Tulane student at the time, developed to regenerate a nipple and areola in breast reconstruction surgery after a mastectomy.
Tulane University administered the first of two Pfizer COVID-19 vaccine shots to roughly 50 employees of its School of Medicine yesterday, from custodial
VAX FACTS: Who gets the vaccine next?
Both Moderna and Pfizer have just started testing the vaccine in kids as young as 12, and it’s unclear if those tests will be done by next school year. Author: Devin Bartolotta / Eyewitness News (WWL) Published: 10:22 PM CST December 25, 2020 Updated: 10:33 PM CST December 25, 2020
NEW ORLEANS Thousands of healthcare providers in Louisiana have gotten the COVID-19 vaccine and those outside of the hospital setting are beginning to receive the shot, too.
Next up: nursing homes. Older Louisianans in congregate settings, and those who care for them, are on deck to receive the COVID-19 vaccine in the coming days.